Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis

Fig. 2

A network meta-analysis of interventional strategies for the treatment of metastatic breast cancer. Bev = bevacizumab, Cap = capecitabine, Vin = vinorelbine, Cyc = cyclophosphamide, Exm = exemestane, Eve = everolimus, Tre = trebananib, Mot = motesanib

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us